BRBS · Blue Ridge Bankshares, Inc.

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Represents forfeiture of unvested performance-based restricted shares, originally awarded on July 1, 2023, for failure to satisfy performance conditions. Total includes other unvested shares that vest in the future.

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Cancellation of performance-based restricted stock.

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Cancellation of performance-based stock

Reflects cancellation of award of performance-based restricted stock.

The amount of beneficial shares owned includes shares of unvested restrick stock that were subsequently cancelled on March 6, 2026 in connection with the Reporting Person's retirement.

Represents forfeiture of performance-based restricted shares for failure to satisfy performance conditions.

Represents forfeiture of performance-based restricted shares for failure to satisfy performance conditions.

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Represents forfeiture of unvested performance-based restricted shares, originally awarded on July 20, 2022, for failure to satisfy performance conditions. Total includes other unvested shares that vest in the future.

Represents forfeiture of unvested performance-based restricted shares, originally awarded July 20, 2022, for failure to satisfy performance conditions.

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Award of performance-based restricted stock subject to company performance achievements and a vesting schedule.

Award of time-based restricted stock subject to a vesting schedule

The warrant is exerciseable to purchase shares of common stock at a parice of $2.50 per share, subject to certain adjustments

The reporting person acquired the warrant in connection with providing investment management services.

Effective as of December 20, 2024, the reporting person no longer manages these securities and therefore no longer has any beneficial ownership in these securities.

The warrant is exercisable to purchase shares of common stock at a price of $2.50 per share, subject to certain adjustments.

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

In the prior Form 4 filing, the number of securities beneficially owned in Colum 5 was inadvertently reported incorrectly due to an administrative error that incorrectly calculated the actual amount of securities beneficially owned following the reported transaction. The current amount of securities the Reporting Person directly beneficially owns is 118,869 as reported in this Form 4.

Stock received in lieu of cash compensation

Restricted stock subject to a vesting schedule

In the prior Form 4 filing, the number of securities beneficially owned in Colum 5 was inadvertently reported incorrectly due to an administrative error that incorrectly calculated the actual amount of securities beneficially owned following the reported transaction. The current amount of securities the Reporting Person directly beneficially owns is 149,651.5013 as reported in this Form 4.

The Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, converted into shares of common stock on a 1-for-4,000 basis.

The Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, is perpetual and therefore has no expiration date.

The Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, converted into shares of common stock on a 1-for-4,000 basis.

The Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, converted into shares of common stock on a 1-for-4,000 basis.

The Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, converted into shares of common stock on a 1-for-4,000 basis.

The Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, is perpetual and therefore has no expiration date.

The shares of Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, underlying the warrant converted into shares of common stock on a 1-for-4,000 basis.

The Series B Warrant was exercisable to purchase shares of Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, at a price of $10,000 per share, subject to certain adjustments. Upon the Mandatory Conversion, the Series B Warrant became exercisable to purchase shares of Common Stock (reflecting a conversion on a 1-for-4,000 basis) at a price of $2.50 per share, subject to certain adjustments.

The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest in the securities.